| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
AJP - Gastrointestinal and Liver Physiology, Vol 264, Issue 2 179-G186, Copyright © 1993 by American Physiological Society
ARTICLES |
D. K. Podolsky
Gastrointestinal Unit, Massachusetts General Hospital, Boston 02114.
The epithelium of the gastrointestinal tract mucosa is a highly dynamic and diverse mixture of cell populations requiring exquisite integration of the processes of cellular proliferation, differentiation, and senescence. It is likely that the proliferative compartment of the intestinal epithelium encompasses a hierarchy of totipotent and pluripotent stem cells in a manner similar to that which generates diversity in hematopoietic cell populations. Identification and characterization of the stem cell and progenitor populations in the intestine has been limited by the absence of markers or culture systems to identify these cells. Regulation of the proliferative compartment may be accomplished through the combined integration of key peptide growth factors and constituents of the extracellular matrix. The relative contribution of the epithelial populations themselves and the contributions made by associated cell populations such as pericryptal fibroblasts remain unclear. Recent studies have suggested that the transforming growth factors-alpha and -beta, two structurally unrelated peptide growth factors, might serve to regulate the balanced proliferation and turnover of intestinal epithelial cells. The proproliferative effects of TGF-alpha may be counterbalanced by the proliferation-inhibiting TGF-beta. Recent studies have demonstrated close interregulation of these peptides, which act through autocrine and paracrine mechanisms in model intestinal epithelial cell lines.
This article has been cited by other articles:
|
|
 |
|
  J. Ueda, H. Saito, H. Watanabe, and B. M. Evers Novel and quantitative DNA dot-blotting method for assessment of in vivo proliferation Am J Physiol Gastrointest Liver Physiol, April 1, 2005; 288(4): G842 - G847. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Potoka, J. S. Upperman, X.-R. Zhang, J. R. Kaplan, S. J. Corey, A. Grishin, R. Zamora, and H. R. Ford Peroxynitrite inhibits enterocyte proliferation and modulates Src kinase activity in vitro Am J Physiol Gastrointest Liver Physiol, November 1, 2003; 285(5): G861 - G869. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Rittler, H. Demmelmair, B. Koletzko, K.-W. Jauch, and W. H. Hartl Effect of tumor removal on mucosal protein synthesis in patients with colorectal cancer Am J Physiol Endocrinol Metab, May 1, 2003; 284(5): E1018 - E1021. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Martin and A. Panja Cytokine regulation of human intestinal primary epithelial cell susceptibility to Fas-mediated apoptosis Am J Physiol Gastrointest Liver Physiol, January 1, 2002; 282(1): G92 - G104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Perreault, J. P. Katz, S. D. Sackett, and K. H. Kaestner Foxl1 Controls the Wnt/beta -Catenin Pathway by Modulating the Expression of Proteoglycans in the Gut J. Biol. Chem., November 9, 2001; 276(46): 43328 - 43333. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yamada, H. Kojima, M. Fujimiya, T. Nakamura, A. Kashiwagi, and R. Kikkawa Differentiation of immature enterocytes into enteroendocrine cells by Pdx1 overexpression Am J Physiol Gastrointest Liver Physiol, July 1, 2001; 281(1): G229 - G236. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Gauthier, C. Harnois, J.-F. Drolet, J. C. Reed, A. Vezina, and P. H. Vachon Human intestinal epithelial cell survival: differentiation state-specific control mechanisms Am J Physiol Cell Physiol, June 1, 2001; 280(6): C1540 - C1554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Samuels, A. L. Knowles, T. Tilignac, E. Debiton, J. C. Madelmont, and D. Attaix Protein Metabolism in the Small Intestine during Cancer Cachexia and Chemotherapy in Mice Cancer Res., September 1, 2000; 60(17): 4968 - 4974. [Abstract] [Full Text]
|
|
|
|
 |
|
 C Schaeffer, M Diab-Assef, M Plateroti, F Laurent-Huck, J M Reimund, M Kedinger, and C Foltzer-Jourdainne Cytokine gene expression during postnatal small intestinal development: regulation by glucocorticoids Gut, August 1, 2000; 47(2): 192 - 198. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Tatsumoto, E. Hiyama, Y. Murakami, Y. Imamura, J. W. Shay, Y. Matsuura, and T. Yokoyama High Telomerase Activity Is an Independent Prognostic Indicator of Poor Outcome in Colorectal Cancer Clin. Cancer Res., July 1, 2000; 6(7): 2696 - 2701. [Abstract] [Full Text]
|
|
|
|
|
|
H. Itoh, H. Kataoka, M. Tomita, R. Hamasuna, Y. Nawa, N. Kitamura, and M. Koono Upregulation of HGF activator inhibitor type 1 but not type 2 along with regeneration of intestinal mucosa Am J Physiol Gastrointest Liver Physiol, April 1, 2000; 278(4): G635 - G643. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Xiao, R. P. Boushey, M. Cino, D. J. Drucker, and P. L. Brubaker Circulating levels of glucagon-like peptide-2 in human subjects with inflammatory bowel disease Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2000; 278(4): R1057 - R1063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Quaroni, J. Q. Tian, M. Goke, and D. K. Podolsky Glucocorticoids have pleiotropic effects on small intestinal crypt cells Am J Physiol Gastrointest Liver Physiol, November 1, 1999; 277(5): G1027 - G1040. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. Boushey, B. Yusta, and D. J. Drucker Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis Am J Physiol Endocrinol Metab, November 1, 1999; 277(5): E937 - E947. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Aliaga, C. Deschenes, J.-F. Beaulieu, E. L. Calvo, and N. Rivard Requirement of the MAP kinase cascade for cell cycle progression and differentiation of human intestinal cells Am J Physiol Gastrointest Liver Physiol, September 1, 1999; 277(3): G631 - G641. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Simmons, J. B. Pucilowska, and P. K. Lund Autocrine and paracrine actions of intestinal fibroblast-derived insulin-like growth factors Am J Physiol Gastrointest Liver Physiol, April 1, 1999; 276(4): G817 - G827. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. W. Houchen, R. J. George, M. A. Sturmoski, and S. M. Cohn FGF-2 enhances intestinal stem cell survival and its expression is induced after radiation injury Am J Physiol Gastrointest Liver Physiol, January 1, 1999; 276(1): G249 - G258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Fiocchi Intestinal inflammation: a complex interplay of immune and nonimmune cell interactions Am J Physiol Gastrointest Liver Physiol, October 1, 1997; 273(4): G769 - G775. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Young, K. G. Biden, L. A. Simms, P. Huggard, R. Karamatic, H. J. Eyre, G. R. Sutherland, N. Herath, M. Barker, G. J. Anderson, et al. HPP1: A transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers PNAS, January 2, 2001; 98(1): 265 - 270. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
